World self-medication industry
The world federation promoting better health through responsible self-medication
NGO in official relations with the World Health Organization

Erectile dysfunction medicine reclassified as pharmacist-only in New Zealand

The New Zealand health authorities have reclassified the generic erectile dysfunction medicine sildenafil as a pharmacist-only medicine, which thus becomes available in New Zealand without a doctor’s prescription but under the supervision of a pharmacist. Pharmacists have been trained through a program designed by the Pharmaceutical Society of New Zealand. It is the first time ever an erectile dysfunction drug is switched to non-prescription status. Tim Roper, a WSMI Board Member and Executive-Director of the New Zealand Self-Medication Industry Association Inc (SMI) said that “reclassifications, or switches, such as this deliver more choice, easier access and potentially lower overall costs to consumers”. WSMI would like to see other similar pharmaceuticals that are deemed safe and effective be reclassified as appropriate in more countries worldwide.
[Download SMI Media Statement]
Array ( [0] => stdClass Object ( [term_id] => 1 [name] => News [slug] => news [term_group] => 0 [term_taxonomy_id] => 1 [taxonomy] => category [description] => WSMI News [parent] => 0 [count] => 156 [object_id] => 2920 [filter] => raw [cat_ID] => 1 [category_count] => 156 [category_description] => WSMI News [cat_name] => News [category_nicename] => news [category_parent] => 0 ) )
Brian McNamara New Chair of WSMI

The Board of Directors of WSMI has elected Mr

read more

UK Study shows a disconnect between how people view self-care and how they act

The “Self Care Nation Report”, commissioned by

read more

Global Study: Men’s Health Perceptions from around the Globe

The results of the survey show that 87 % of men

read more